Welcome to our dedicated page for Columbia Financ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to trace how rising rates hit Columbia Financial’s net interest margin or when directors last bought shares? Community banks pack hundreds of pages of regulatory detail into every filing, and Columbia Financial, Inc. (CLBK) is no exception.
Our platform turns those dense documents into clear answers. Stock Titan’s AI reads each submission the second it hits EDGAR, so you receive Columbia Financial Form 4 insider transactions real-time alerts instead of hunting through exhibits. Dive into a concise dashboard where:
- 10-Ks & 10-Qs decoded: The engine delivers a plain-English breakdown of interest income, loan loss provisions, and segment performance—Columbia Financial annual report 10-K simplified and every Columbia Financial quarterly earnings report 10-Q filing distilled in minutes.
- Form 4 tracking: Instantly spot Columbia Financial executive stock transactions Form 4 and monitor buying or selling trends with AI context.
- 8-K event clarity: Whether it’s a branch acquisition or a sudden credit-loss update, get Columbia Financial 8-K material events explained without legal jargon.
Common searches such as “Columbia Financial SEC filings explained simply” or “understanding Columbia Financial SEC documents with AI” lead here because we answer them directly. You can also explore the Columbia Financial proxy statement executive compensation section to see how leadership pay aligns with community-bank performance, and our engine provides concise Columbia Financial earnings report filing analysis.
From rate-sensitive margin tables to Columbia Financial insider trading Form 4 transactions, every disclosure is summarized, searchable, and delivered in real time—so analysts, portfolio managers, and community investors spend time making decisions, not turning pages.
Columbia Financial, Inc. (CLBK) announced it will make a slide presentation available to analysts and prospective investors on November 10, 2025. The materials cover the company’s operating and growth strategies and financial performance and will be posted on the company’s website the same day.
In connection with this Regulation FD disclosure, the presentation is furnished as Exhibit 99.1. The filing lists the exhibit and confirms public availability to ensure broad, simultaneous access to the information.
Columbia Financial, Inc. (CLBK) reported stronger quarterly results. For the three months ended September 30, 2025, net income was $14.9 million versus $6.2 million a year ago, and diluted EPS was $0.15 versus $0.06. Net interest income rose to $57.4 million from $45.3 million as interest expense declined to $63.0 million from $70.6 million, while total interest income increased to $120.4 million from $115.9 million. The provision for credit losses was $2.3 million compared with $4.1 million.
Non-interest income was $9.9 million versus $9.0 million, supported by higher loan fees and changes in equity securities’ fair value. Non-interest expense increased to $45.1 million from $42.8 million, mainly in compensation and occupancy. For the nine months, net income was $36.1 million versus $9.6 million, with diluted EPS of $0.35 versus $0.09. As of September 30, 2025, total assets were $10.86 billion, loans receivable, net were $8.21 billion, deposits were $8.24 billion, and borrowings were $1.26 billion. Accumulated other comprehensive loss narrowed to $88.9 million.
Columbia Financial (CLBK) reported an insider filing by its EVP & CIO. The Form 4 shows a transaction on 10/31/2025 coded “F” for 522 shares at $14.75 per share. Following this, the officer directly owned 4,857 common shares. Indirect holdings include 545.5975 shares by a stock-based deferral plan, 1,541.376 by a 401(k), 2,150 by an ESOP, and 437 by a SERP. Additional indirect positions include stock awards of 9,690, 11,315, and 11,018 shares, plus stock options covering 12,985, 8,459, 8,296, and 19,086 shares with exercise prices between $15.94 and $20.54 and expirations through 2035.
Columbia Financial (CLBK) reported an insider transaction by its SEVP & Chief Risk Officer. On 10/31/2025, the officer acquired 43.2854 shares of common stock at $14.75, recorded as phantom stock purchased under the Bank’s Stock Based Deferral Plan, which will be settled in shares upon distribution.
Following the transaction, the officer beneficially owned 7,981.3625 shares indirectly via the Stock‑Based Deferral Plan. Additional positions include 60,769 shares held directly, and indirect holdings through retirement and incentive plans. Derivative holdings include stock options for 188,235 shares at $15.60 expiring 07/23/2029, 12,030 at $15.94 expiring 05/01/2033, 8,850 at $16.49 expiring 03/06/2034, and 20,310 at $16.23 expiring 03/03/2035.
Columbia Financial, Inc. (CLBK) reported an insider transaction by its SEVP & Head of Consumer Banking on 10/31/2025. The filing shows an automatic acquisition of 22.6861 shares of common stock at $14.75 through the Stock‑Based Deferral Plan (phantom stock settled in shares upon distribution).
Following the transaction, beneficial holdings include 13,459.705 shares indirect via the Stock‑Based Deferral Plan, 64,281 shares direct, and indirect amounts via plans/awards: ESOP 6,683, SERP 6,459, SIM 4,683, Stock Award II 14,470, Stock Award III 12,672, and Stock Award IV 12,288.
Derivative holdings listed are stock options for 155,294 shares at $15.60 (exp. 07/23/2029), 12,632 at $15.94 (exp. 05/01/2033), 9,292 at $16.49 (exp. 03/06/2034), and 21,289 at $16.23 (exp. 03/03/2035).
Columbia Financial (CLBK) reported an insider transaction by its President & CEO and Director. On 10/31/2025, the reporting person acquired 121.1613 shares of common stock at $14.75 through the Stock-Based Deferral Plan.
Following the transaction, indirect holdings under the Stock-Based Deferral Plan were 66,042.2359 shares. The reporting person also holds stock options for 656,471 shares (exercise price $15.6, exercisable 07/23/2020, expiring 07/23/2029), and additional grants for 37,894 (at $15.94), 37,168 (at $16.49), and 94,749 (at $16.23) shares with later expirations.
Columbia Financial (CLBK) reported an insider transaction by its SEVP & Head of Consumer Banking. On 10/17/2025, the officer acquired 24.3715 shares of common stock at $13.73 through the company’s Stock-Based Deferral Plan, a non-qualified plan that settles in shares upon distribution.
Following the transaction, the officer held 13,437.0189 shares indirectly via the deferral plan, alongside other reported holdings including 64,281 shares direct and positions via ESOP, SERP, SIM, and performance-based stock awards. The filing also lists stock options outstanding, including 155,294 options at an exercise price of $15.60 expiring on 07/23/2029, plus additional tranches at $15.94, $16.49, and $16.23 with expirations through 2035.
Columbia Financial (CLBK) insider filing: the SEVP & Chief Risk Officer reported an acquisition on 10/17/2025. The filing shows 46.5011 phantom stock units acquired at $13.73 via the Stock-Based Deferral Plan. Following this, the officer reports 7,938.0771 units beneficially owned in the plan.
Other reported holdings include 60,769 shares directly, plus additional interests via 401(k), ESOP, SERP, SIM, and performance-based stock awards. Derivative holdings include stock options for 188,235 shares at $15.60 (fully vested) and other option grants with scheduled vesting.
Columbia Financial (CLBK) reported an insider transaction by its President & CEO (also a Director). On 10/17/2025, the executive acquired 130.1624 common stock units at $13.73 through the Bank’s Stock‑Based Deferral Plan.
Per the plan, these are phantom stock interests that will be settled in shares upon distribution to the reporting person. Following this transaction, 65,921.0746 units were beneficially owned under the deferral plan.
The filing also lists outstanding stock options, including 656,471 options at an exercise price of $15.60 expiring on 07/23/2029, and additional grants of 37,894 at $15.94 (exp. 05/01/2033), 37,168 at $16.49 (exp. 03/06/2034), and 94,749 at $16.23 (exp. 03/03/2035).
FAQ
What is the current stock price of Columbia Financ (CLBK)?
What is the market cap of Columbia Financ (CLBK)?
